Non-interventional Study (NIS) on Sodium-glucose Co-transporter-2 Inhibitors (SGLT2i) Use in France

NCT05882071 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

547150

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Sodium/glucose cotransporter-2 inhibitors (SGLT2i)

Sponsor

Boehringer Ingelheim